Delivery Order SPE2DB24D2101-SPE2DB25FKLFQ
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,543.03 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $12,246.66, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $36,782.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 4, 2025 with a completion date of June 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ELIQUIS 5 MG TABLET 60S. The $34,745.56 firm fixed-price delivery order contract has a completion date of May 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,054.99, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,281.53 Firm Fixed Price contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The $10,160.60 firm fixed price delivery order, issued under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, has a performance period through March 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is the sole awardee on...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $3,033.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 21, 2025, with a completion date of May 22, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $17,980.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,279.69 firm fixed-price delivery order has a completion date of May 22, 2024 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...